microRNA 4686 (MIR4686)

microRNA 4686 (MIR4686) is a human microRNA, a short (20–24 nucleotide), non-coding RNA molecule involved in post-transcriptional regulation of gene expression. Like other microRNAs, it is transcribed by RNA polymerase II, processed through the Drosha and Dicer enzymes into a mature form, and then incorporated into the RNA-induced silencing complex (RISC) to regulate gene expression by binding to target mRNAs, leading to translational inhibition or mRNA destabilization. Specific biological roles for MIR4686 have not been elucidated, but microRNAs as a class are known to regulate diverse cellular processes including cell proliferation, differentiation, survival, and are frequently dysregulated in diseases such as cancer. No specific disease associations are documented for MIR4686; for microRNAs in general, roles include: Cancer, Cell proliferation, Cell differentiation, Other (general gene regulation and buffering of gene expression). However, these are functions of microRNAs as a class, not MIR4686 specifically, for which there is no direct evidence in the available sources. Circulating microRNAs may serve as biomarkers for disease states, but MIR4686 itself is not currently used as a biomarker. No known safety concerns or therapeutic challenges are described for MIR4686 specifically. General challenges for targeting microRNAs include off-target effects and delivery issues. MIR4686 thus represents a validated human microRNA gene with general regulatory function typical of the miRNA class, but no specific disease associations, drug interactions, or therapeutic targeting evidence found in current literature.

Other names

hsa-mir-4686MIR4686miR-4686

General mechanisms for targeting microRNAs (not MIR4686 specifically) may include: - Use of antisense oligonucleotides to inhibit microRNA function - Use of synthetic mimics to increase microRNA activity. For MIR4686 specifically, no mechanisms of therapeutic action have been described.